A Call to Investigate the Association Between Histoplasmosis and Fatigue
Open Access
- 19 June 2026
- journal article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (7)
Abstract
Historically, infections are subjectively associated with fatigue, a common yet poorly delineated syndrome. The impact on patient quality of life is the ultimate justification to evaluate fatigue in patients with infections. While fungal infections are subjectively associated with fatigue, there are minimal quantifiable fungal research outcomes that evaluate histoplasmosis and fatigue.Keywords
Funding Information
- National Center for Advancing Translational Sciences, National Institutes of Health
- Washington University Institute of Clinical and Translational Sciences (UL1 TR002345)
This publication has 7 references indexed in Scilit:
- 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Histoplasmosis: Treatment of Asymptomatic Histoplasma Pulmonary Nodules (Histoplasmomas) and Mild or Moderate Acute Pulmonary Histoplasmosis in Adults, Children, and Pregnant PeopleClinical Infectious Diseases, 2025
- Post-COVID-19 fatigue: A systematic reviewFrontiers in Psychiatry, 2022
- Management of Histoplasmosis by Infectious Disease PhysiciansOpen Forum Infectious Diseases, 2022
- Lasting Immunological Imprint of Primary Epstein-Barr Virus Infection With Associations to Chronic Low-Grade Inflammation and FatigueFrontiers in Immunology, 2021
- The global epidemiology of emerging Histoplasma species in recent yearsStudies in Mycology, 2020
- Prevalence and factors associated with fatigue in the Lausanne middle-aged population: a population-based, cross-sectional surveyBMJ Open, 2019
- Development of the PROMIS-based Research Assessment and Clinical Tool-Fatigue (ReACT-F)Supportive Care in Cancer, 2019